Patient Condition
Retired nurse, memory dropped for a year and a half, worried about genetic risk (father suffered from AD). Cleveland Clinic assessment, MMSE score was 23 points, early AD was confirmed by biomarker test, and APOE ε4 was positive.
Treatment Timeline
| Phase | Details | Date |
|---|
| Standardized assessment and early diagnosis | | |
| Aduhelm (Aducanumab) treatment initiation | | |
| High-intensity cognitive rehabilitation + lifestyle intervention | | |
| Maintenance treatment and long-term cognitive protection | | |
Treatment Outcome
| before | MMSE score 23, memory decreased, anxiety about genetic risks, poor sleep quality |
|---|
| after | MMSE score 27 points (improvement 4 points), cognitive function is stable, anxiety is significantly improved, and sleep quality is improved |
|---|
| highlight | Psychological status has improved significantly and patients are confident in treatment |
|---|